From the Journals

Dupilumab and Lymphoma Risk in AD?

Dupilumab is safe from a lymphoma-risk perspective in atopic dermatitis and other type 2 inflammatory diseases, based on real-world data.

Share

Original Source(s)

Dupilumab and Lymphoma Risk in AD?

Dupilumab is safe from a lymphoma-risk perspective in atopic dermatitis and other type 2 inflammatory diseases, based on real-world data.

  • by Julia Cipriano, MS, CMPP

  • February 9, 2026

  • 3 min

Related Content

Does Air Pollution Affect Skin Health?

Large systematic review finds consistent associations across conditions but highlights low certainty driven by bias and study heterogeneity.

Oral TYK2 Inhibition in Atopic Dermatitis

Phase 2 trial evaluated once-daily oral TYK2 inhibition in adults with moderate to severe AD.

What Causes the Itch in Dermatitis?

Scientists discover the mechanism that drives inflammation and itching in the chronic skin condition

  • February 3, 2026

  • 2 min